 | Related Articles |
Management of methicillin-resistant Staphylococcus aureus infections.
Clin Microbiol Infect. 2009 Feb;15(2):125-36
Authors: Garau J, Bouza E, Chastre J, Gudiol F, Harbarth S
This review addresses selected aspects of the management of severe healthcare-associated infections due to methicillin-resistant Staphylococcus aureus (MRSA), including the limitations of current therapy, potential alternative agents, new therapeutic options, clinical approaches to MRSA bacteraemia/endocarditis and ventilator-associated pneumonia, and strategies to improve outcomes in patients with severe MRSA infections.
PMID: 19291144 [PubMed - indexed for MEDLINE]